KLEPTOSE® HP HPB - Hydroxypropyl betacyclodextrin
![KLEPTOSE® HP HPB - Hydroxypropyl betacyclodextrin](/46/product/02/22/63/roquette-biopharma-scientist-looking-at-ampoule-medication-or-vaccine-2020-02-1338.png)
Product Description
ROQUETTE FRERES SA
![ROQUETTE FRERES SA](/Logo%20Roquette2-comp243425.png)
-
FR
-
2015On CPHI since
-
5000+Employees
Company types
Categories
Specifications
ROQUETTE FRERES SA
![ROQUETTE FRERES SA](/Logo%20Roquette2-comp243425.png)
-
FR
-
2015On CPHI since
-
5000+Employees
Company types
More Products from ROQUETTE FRERES SA (4)
-
Product PEARLITOL® - Mannitol
PEARLITOL® Mannitol pharma range is used as a filler and filler/binder as well as a bulk sweetener. The PEARLITOL® range offers a unique blend of exceptional physical and chemical stability and no hygroscopicity.PEARLITOL® can be used in various oral dosage forms in both pharmaceutical and nutraceutic... -
Product MICROCEL® - Microcrystalline cellulose
A microcrystalline cellulose with filler-binder properties and a certain capacity to act as a disintegrant. -
Product KLEPTOSE® - Betacyclodextrin
KLEPTOSE® Betacyclodextrins are efficient solubilisation, stabilization enhancers and taste-masking agents. A full range is available for use in many dosage forms, from solid to liquid. -
Product LYCADEX® PF - Pyrogen-free dextrose
A physiological sugar used as an active isotonic agent or a carbohydrate energy source in parenteral infusion or injectable therapies.
ROQUETTE FRERES SA resources (3)
-
News Roquette to advance drug delivery research with new US Innovation Center
The new facility will focus on the research of excipients for oral dosage forms, drug delivery systems, nutraceutical APIs and innovative pharma ingredients -
Brochure BROCHURE - Roquette Pharmaceuticals and Nutraceuticals
Discover the wide range of products by Roquette in Pharmaceuticals and Neutraceuticals -
News Vaccine manufacturing demand has had limited effect on regenerative medicine sector, panel tells CPHI audience
The ramping up of vaccine manufacturing demand amid the COVID-19 pandemic had an initial impact on cell and gene therapy production but the regenerative medicine sector has largely weathered the storm, according to senior industry figures in a recent panel discussion at the CPHI Festival of Pharma virtual event.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance